Published December 5, 2022
| Version v1
Dataset
Open
A novel preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs - Supplementary Material
- 1. Novartis Institutes for Biomedical Research, Cambridge, MA, United States
- 2. Novartis Institutes for Biomedical Research, Basel, Switzerland
Description
These data constitute the supplementary material to the manuscript and are required as input for the Jupyter notebooks that contain the code for reproducing reported results.
Files
AE_vs_assay_pairs_logistic_modelling_update.txt
Files
(134.3 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:919c5137fbf13fa2159373b42903ad0c
|
94.6 kB | Preview Download |
|
md5:0bec1bc0b1a0c35070a974d4079ea6a8
|
2.4 kB | Preview Download |
|
md5:5bfe34bd519e8c788f459e45d12c720e
|
6.3 kB | Preview Download |
|
md5:6b7aaf6e296f628560ba5348d3b87cb4
|
587.8 kB | Preview Download |
|
md5:3dc962ce871cd32a92af35aefbd12507
|
88.5 MB | Preview Download |
|
md5:d3cfd99bf14778a8cee77e3227b2d30f
|
12.2 MB | Download |
|
md5:42205ba4eebc402b83ae28e777949489
|
52.4 kB | Preview Download |
|
md5:bcfc245c7fc5b3593f9f9949bfdc9e0d
|
10.6 MB | Preview Download |
|
md5:621c6363ba55699d476637bc60558870
|
16.1 MB | Preview Download |
|
md5:a2d0de12c759c709ac634bf021581ca6
|
80.1 kB | Preview Download |
|
md5:d60aad465bd28acbcc187d7a2369c89f
|
11.1 kB | Preview Download |
|
md5:1554ef3e034cd36f9a00158ab345aa67
|
6.5 kB | Preview Download |
|
md5:a80403997cedac3a709a9f8676143727
|
16.3 kB | Preview Download |
|
md5:bab43165a516f5e7238b8ed6afc7aa2c
|
1.7 MB | Download |
|
md5:71da7c56a5b10d9f3715bdf1c49df7ed
|
4.4 MB | Preview Download |